allergic rhinitis
Conditions
Interventions
Experimental group :placebo
Experimental group :Qingfei Jianpi desensitization
Sponsors
Beijing Tongren Hospital ,Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Patients who meet the diagnostic criteria of Western medicine and TCM syndrome differentiation criteria; (2) At least 2 years in the same season, the onset season of each year is basically the same, and it is consistent with the pollination period of sensitized pollen; (3) The age ranged from 18 to 65 years; (4)Voluntarily participate in this experimental study and voluntarily terminate all treatments that may affect the evaluation of the tested drug; (5)Sign informed consent
Exclusion criteria
Exclusion criteria: (1)Those who have taken steroids in recent 2 weeks and antihistamines or topical steroids in 1 week; (2)Perennial allergic rhinitis, acute rhinitis, or severe asthma combined with severe nasal septum deviation and hypertrophic rhinitis; (3)Patients with serious primary diseases and psychosis such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system; (4)Allergic to the drug; (5)A woman who is pregnant, lactating or preparing for pregnancy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptom score; | — |
Secondary
| Measure | Time frame |
|---|---|
| nasal resistance;TCM syndrome score;Nasal sound reflection;RQLQ score; | — |
Countries
CHINA
Contacts
Public Contactqujing
Outcome results
None listed